The limb-girdle muscular dystrophies - Multiple genes, multiple mechanisms

Human Molecular Genetics

Volumn 8, Issue 10, 1999, Pages 1875-1882

  Bushby, Katharine M D ^a  

^a Department of Human Genetics ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CAVEOLIN; DYSFERLIN; DYSTROPHIN; GENE PRODUCT; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE MUTATION; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

CALPAIN; CAVEOLIN 3; CAVEOLINS; GENES, DOMINANT; GENES, RECESSIVE; HUMANS; MEMBRANE PROTEINS; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; MUTATION; PHENOTYPE; VARIATION (GENETICS);

EID: 0032882445     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.10.1875     Document Type: Review

References (86)

1. Bushby, K.M.D. and Beckmann, J.S. (1995) Report of the 30th and 31st ENMC international workshop - the limb-girdle muscular dystrophies, and proposal for a new nomenclature. Neuromusc. Disord., 5, 337-344.
2. Bushby, K.M.D. (1995) Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC consortium on limb-girdle dystrophies. Neuromusc. Disord., 5, 71-74.
3. Ozawa, E., Noguchi, S., Mizuno, Y., Hagiwara, Y. and Yoshida, M. (1998) From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve, 21, 421-438.
4. Speer, M.C., Vance, J.M., Grubber, J.M., Graham, F.L., Stajich, J.M., Viles, K.D., Rogala, A., McMichael, R., Chutkow, J., Goldsmith, C., Tim, R.W. and Pericak-Vance, M.A. (1999) Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7. Am. J. Hum. Genet., 64, 556-562.
5. McNally, E.M., de Sa Moreira, E., Duggan, D.J., Bonnemann, C.G., Lisanti, M.P., Lidov, H.G.W., Vainzof, M., Passos-Bueno, M.R., Hoffman, E.P., Zatz, M. and Kunkel, L.M. (1998) Caveolin-3 in muscular dystrophy. Hum. Mol. Genet., 7, 871-877.
6. Minetti, C., Sotgia, F., Bruno, C., Scartezzini, P., Broda, P., Bado, M., Masetti, E., Mazzocco, M., Egeo, A., Donati, M.A., Volonte, D., Galbiati, F., Cordone, G., Bricarelli, F.D., Lisanti, M.P. and Zara, F. (1998) Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy, Nature Genet., 18, 365-368.
7. Messina, D.L., Speer, M.C., Pericak-Vance, M.A. and McNally, E.M. (1997) Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am. J. Hum. Genet., 61, 909-917.
8. Speer, M.C., Yamaoka, L.H., Gilchrist, J.M., Gaskell, C.P., Stajich, J.M., Vance, J.M., Katzantsev, A., Lastra, A.A., Haynes, C.S., Beckmann, J.S., Cohen, D., Weber, J.L., Roses, A.D. and Pericak-Vance, M.A. (1992) Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form of chromosome 5q. Am. J. Hum. Genet., 50, 1211-1217.
9. van der Kooi, A.J., van Meegen, M., Ledderhof, T.M., McNally, E.M., de Visser, M. and Bolhuis, P.A. (1997) Genetic localisation of a newly recognised autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. Am. J. Hum. Genet., 60, 891-895.
10. Bashir, R., Britton, S., Strachan, T., Keers, S., Vafiadaki, E., Lako, M., Richard, I., Marchand, S., Bourg, N., Argov, Z., Sadeh, M., Mahjneh, I., Marconi, G., Passos-Bueno, M.R., de Sa Moreira, E., Zatz, M., Beckmann, J.S. and Bushby, K. (1998) A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nature Genet., 20, 37-42.
11. Liu, J., Aoki, M., Illa, I., Wu, C., Fardeau, M., Angelini, C., Serrano, C., Urtizberea, J.A., Hentati, F., Ben Hamida, M., Bohlega, S., Culper, E.J., Amato, A.A., Bossie, K., Oeltjen, J., Bejaoui, K., McKenna-Yasek, D., Hosler, B.A., Schurr, E., Arahata, K., de Jong, P.J. and Brown, R.H. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nature Genet., 21, 31-36.
12. Nigro, V., Moreira, E.S., Piluso, G., Vainzof, M., Belsito, A., Politano, L., Puca, A.A., Passos-Bueno, M.R. and Zatz, M. (1996) Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene. Nature Genet., 14, 195-198.
13. Bonnemann, C.G., Modi, R., Noguchi, S., Mizuno, Y., Yoshida, M., Gussoni, E., Duggan, D.J., Angelini, C., Hoffman, E.P., Ozawa, E. and Kunkel, L.M. (1995) β-Sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nature Genet., 11, 266-273.
14. Noguchi, S., McNally, E.M., Ben Othmane, K., Hagiwara, Y., Mizuno, Y., Yoshida, K., Yamamoto, H., Bonnemann, C.G., Gussoni, E., Denton, P., Kyriakides, T., Middleton, L., Hentati, F., Ben Hamida, M., Nonaka, I., Vance, J.M., Kunkel, L.M. and Ozawa, E. (1995): Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science, 270, 819-822.
15. Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C., Hillaire, D., Passos-Bueno, M., Zatz, M., Tischfield, J.A., Fardeau, M., Jackson, C.E., Cohen, D. and Beckmann, J.S. (1995) Mutations in the proteolytic enzyme, calpain 3, cause limb girdle muscular dystrophy type 2A. Cell, 81, 27-40.
16. Roberds, S., Leturcq, F., Allamand, V., Piccolo, F., Jeanpierre, M., Anderson, R.D., Lim, L.E., Lee, J.C., Tomé, F.M.S., Romero, N.B., Fardeau, M., Beckmann, J.S., Kaplan, J. and Campbell, K.P. (1994) Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell, 78, 625-633.
17. Weiler, T., Greenberg, C.R., Zelinski, T., Nylen, E., Coghlan, G., Crumley, M.J., Fujiwara, T.M., Morgan, K. and Wrogemann, K. (1998) A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-33: evidence for another limb-girdle muscular dystrophy locus. Am. J. Hum. Genet., 63, 140-147.
18. Moreira, E.S., Vainzof, M., Marie, S.K., Sertie, A.L., Zatz, M. and Passos-Bueno, M.R. (1997) The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am. J. Hum. Genet., 61, 151-159.
19. Bushby, K. (1999) Making sense of the limb-girdle muscular dystrophies. Brain, 122, 1403-1420.
20. Anderson, L.V.B. (1996) Optimized protein diagnosis in the autosomal recessive limb-girdle muscular dystrophies. Neuromusc. Disord., 6, 443-446.
21. Anderson, L.V.B. and Davison, K. (1999) Multiplex western blotting for the analysis of muscular dystrophy proteins. Am. J. Pathol., 154, 1017-1022.
22. Urtasun, M., Saenz, A., Roudaut, C., Poza, J.J., Urtizberea, J.A., Cobo, A.M., Richard, I., Bragado, F.G., Leturcq, F., Kaplan, J.C., Masso, J.F.M., Beckmann, J.S. and de Munain, A.L. (1998) Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain, 121, 1735-1747.
23. Dincer, P., Leturcq, F., Richard, I., Piccolo, F., Yalnizoglu, D., de Toma, C., Akcoren, Z., Broux, O., Deburgrave, N., Brenguier, L., Roudaut, C., Urtizberea, A., Jung, D., Tan, E., Jeanpierre, M., Campbell, K.P., Kaplan, J., Beckmann, J.S. and Topaloglu, H. (1997) A biochemical, genetic and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann. Neurol., 42, 222-229.
24. Duggan, D.J., Manchester, D., Stears, K.P., Mathews, D.J., Hart, C. and Hoffman, E.P. (1997) Mutations in the δ-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Neurogenetics, 1, 49-58.
25. Richard, I., Brenguier, L., Dincer, P., Roudaut, C., Bady, B., Burgunder, J., Chemaly, R., Garcia, C.A., Halaby, G., Jackson, C.E., Kurnit, D.M., Lefranc, G., Legum, C., Loiselet, J., Merlini, L., Nivelon-Chevalier, A., Ollagnon-Roman, E., Restagno, G., Topaloglu, H. and Beckmann, J.S. (1997) Mutliple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am. J. Hum. Genet., 60, 1128-1138.
26. Duggan, D.J. and Hoffman, E.P. (1996) Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex. Neuromusc. Disord., 6, 475-482.
27. Piccolo, F., Jeanpierre, M., Leturcq, F., Dode, C., Azibi, K., Toutain, A., Merlini, L., Jarre, L., Navarro, C., Krishnamoorthy, R., Tome, F.M.S., Urtizberea, J.A., Beckmann, J.S., Campbell, K.P. and Kaplan, J. (1996) A founder mutation in the γ-sarcoglycan gene of Gypsies possibly predating their migration out of India. Hum. Mol. Genet., 5, 2019-2022.
28. Pogue, R., West, S. and Bushby, K. (1998) Multiplex SSCP and heteroduplex analysis with southern hybridisation for large-scale mutation detection: a new technique for the investigation of genetically heterogeneous disease. Genomics, 54, 1-4.
29. Duggan, D.J., Gorospe, J.R., Fanin, M., Hoffman, E.P. and Angelini, C. (1997) Mutations in the sarcoglycan genes in patients with myopathy. N. Engl. J. Med., 336, 618-624.
30. Chou, F., Angelini, C., Daentl, D., Garcia, C., Greco, C., Hausmanowa-Petrusewicz, I., Fidzianska, A., Wessel, H. and Hoffman, E. (1999) Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population. Neurology, 52, 1015-1020.
31. Bashir, R., Britton, S., Strachan, T., Keers, S., Vafiadaki, E., Lako, M., Richard, I., Marchand, S., Bourg, N., Argov, Z., Sadeh, M., Mahjneh, I., Marconi, G., Passos-Bueno, M.R., de Sa Moreira, E., Zatz, M., Beckmann, J.S. and Bushby, K. (1998) A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nature Genet., 20, 37-42.
32. Bonne, G., di Barletta, M.R., Varnous, S., Becane, H., Hammouda, E., Merlini, L., Muntoni, F., Greenberg, C.R., Gary, F., Urtizberea, J.A., Duboc, D., Fardeau, M., Toniolo, D. and Schwartz, K. (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nature Genet., 21, 285-288.
33. Bonne, G., di Barletta, M.R., Varnous, S., Becane, H., Hammouda, E., Urtizberea, J.A., Duboc, D., Toniolo, D., Fardeau, M. and Schwartz, K. (1998) Genetic localisation of autosomal dominant Emery-Dreifuss muscular dystrophy. Muscle Nerve, S7, S65 (abstract).
34. Feit, H., Silbergleit, A., Schneider, L.B., Gutierrez, J.A., Fitoussi, R., Reyes, C., Rouleau, G.A., Brais, B., Jackson, C.E., Beckmann, J.S. and Seboun, E. (1998) Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localisation to 5q31. Am. J. Hum. Genet., 63, 1732-1742.
35. Engelman, J.A., Zhang, X., Galbiati, F., Volonte, D., Sotgia, F., Pestell, R.G., Minetti, C., Scherer, P.E., Okamoto, T. and Lisanti, M.P. (1998) Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimers disease and muscular dystrophy. Am. J. Hum. Genet., 63, 1578-1587.
36. Song, K.S., Scherer, P.E., Tang, Z., Okamoto, T., Li, S., Chafel, M., Chu, C., Kohtz, D.S. and Lisanti, M.P. (1996) Expression of caveolin-3 in skeletal, cardiac and smooth muscle cells. J. Biol. Chem., 271, 15160-15165.
37. Crosbie, R.H., Yamada, H., Venzke, D.P., Lisanti, M.P. and Campbell, K.P. (1998) Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. FEBS Lett., 427, 279-282.
38. Straub, V. and Campbell, K.P. (1997) Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol., 10, 168-175.
39. Angelini, C., Fanin, M., Menegazzo, E., Freda, M.P., Duggan, D.J. and Hoffman, E.P. (1998) Homozygous α-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient. Muscle Nerve, 21, 769-775.
40. Quinlivan, R.M., Robb, S.A., Sewry, C., Dubowitz, V., Piccolo, F. and Kaplan, J. (1997) Absence of alpha-sarcoglycan and novel missense mutations in the alpha-sarcoglycan gene in a young British girl with muscular dystrophy. Dev. Med. Child Neurol., 39, 770-774.
41. Duggan, D.J., Fanin, M., Pegoraro, E., Angelini, C. and Hoffman, E.P. (1996) α-Sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations. J. Neurol. Sci., 140, 30-39.
42. Jeanpierre, M., Carrie, A., Piccolo, F., Leturcq, F., Azibi, K., Toma, C., Beldjord, C., Merlini, L., Voit, T., Romero, J., Sunada, Y., Tome, F.M.S., Fardeau, M., Campbell, K.P. and Kaplan. J. (1996) From adhalinopathies to alpha-sarcoglycanopathies: an overview. Neuromusc. Disord., 6, 463-466.
43. Carrie, A., Piccolo, F., Leturcq, F., de Toma, C., Azibi, K., Beldjord, C., Vallat, J., Merlini, L., Voit, T., Sewry, C., Urtizberea, J.A., Romero, N., Tome, F.M.S., Fardeau, M., Sunada, Y., Campbell, K.P., Kaplan, J. and Jeanpierre, M. (1997) Mutational diversity and hot spots in the α-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J. Med. Genet., 34, 470-475.
44. Bonnemann, C.G., Passos-Bueno, M.R., McNally, E.M., Vainzof, M., Moreira, E.S., Marie, S.K., Pavanello, R.C.M., Noguchi, S., Ozawa, E., Zatz, M. and Kunkel, L.M. (1996) Genomic screening for β-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD2E). Hum. Mol. Genet., 5, 1953-1961.
45. Duclos, F., Broux, O., Bourg, N., Straub, V., Feldman, G.L., Sunada, Y., Lim, L.E., Piccolo, F., Cutshall, S., Gary, F., Quetier, F., Kaplan, J., Jackson, C.E., Beckmann, J.S. and Campbell, K.P. (1998) β-Sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate. Neuromusc. Disord., 8, 30-38.
46. van der Kooi, A.J., de Visser, M., van Meegen, M., Ginjaar, H.B., van Essen, A.J., Jennekens, F.G.I., Jongen, P.J.H., Leschot, N.J. and Bolhuis, P.A. (1998) A novel y-sarcoglycan mutation causing mild limb girdle muscular dystrophy. Neuromusc. Disord., 8, 305-308.
47. Jung, D., Leturcqu, F., Sunada, Y., Duclos, F., Tome, F.M.S., Moomaw, C., Merlini, L., Azibi, K., Chaouch, M., Slaughter, C., Fardeau, M., Kaplan, J. and Campbell, K.P. (1996) Absence of y-sarcoglycan (35 DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12. FEBS Lett., 381, 15-20.
48. Moreira, E.S., Vainzof, M., Marie, S.K., Nigro, V., Zatz, M. and Passos-Bueno, M. (1998) A first missense mutation in the δ sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies. J. Med. Genet., 35, 951-953.
49. Jones, K.J., Kim, S.S. and North, K.N. (1998) Abnormalities of dystrophin, the sarcoglycans, and laminin α2 in the muscular dystrophies. J. Med. Genet., 35, 379-386.
50. Bushby, K., Anderson, L.V.B., Sewry, C., Pogue, R., Taylor. J.A., Pollitt, C. and Muntoni, F. (1997) Dystrophinopathy or sarcoglycanopathy - the importance of a full diagnostic assessment in suspected manifesting carriers of Duchenne and Becker muscular dystrophy. J. Med. Genet., 34, S54 (abstract).
51. Vainzof, M., Passos-Bueno, M.R., Canovas, M., Moreira, E.S., Pavanello, R.C.M., Marie, S.K., Anderson, L.V.B., Bonnemann, C.G., McNally, E.M., Nigro, V., Kunkel, L.M. and Zatz, M. (1996) The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum. Mol. Genet., 5, 1963-1969.
52. McNally, E.M., Ly, C.T. and Kunkel, L.M. (1998) Human ε-sarcoglycan is highly related to α-sarcoglycan (adhalin) the limb girdle muscular dystrophy 2D gene. FEBS Lett., 422, 27-32.
53. Ettinger, A.J., Feng, G. and Sanes, J.R. (1997) ε-Sarcoglycan, a broadly expressed homologue of the gene muated in limb-girdle muscular dystrophy 2D. J. Biol. Chem., 272, 32534-32538.
54. Durbeej, M., Henry, M.D. and Campbell, K.P. (1998) Dystroglycan in development and disease. Curr. Opin. Cell Biol., 10, 594-601.
55. Yoshida, M., Suzuki, A., Yamamoto, H., Noguchi, S., Mizuno, Y. and Ozawa, E. (1994) Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl β-D-glucoside. Eur. J. Biochem., 222, 1055-1061.
56. Duclos, F., Straub, V., Moore, S.A., Venzke, D.P., Hrstka, R.F., Crosbie, R.H., Durbeej, M., Lebakken, C.S., Ettinger, A.J., van der Meulen, J., Holt, K.H., Lim, L.E., Sanes, J.R., Davidson, B.L., Faulkner, J.A., Williamson, R. and Campbell, K.P. (1998) Progressive muscular dystrophy in α-sarcoglycan-deficient mice. Cell Biol., 142, 1461-1471.
57. Straub, V., Duclos, F., Venzke, D.P., Lee, J.C., Cutshall, S., Leveille, C.J. and Campbell, K.P. (1998) Animal model: molecular pathogenesis of muscle degeneration in the δ-sarcoglycan-deficient hamster. Am. J. Pathol., 153, 1623-1630.
58. Straub, V., Rafael, J.A., Chamberlain, J.S. and Campbell, K.P. (1997) Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. Cell Biol., 139, 375-385.
59. Holt, K.H. and Campbell, K.P. (1998) Assembly of the sarcoglycan complex: insights for muscular dystrophy. Biol. Chem., 273, 34667-34670.
60. Betto, R., Senter, L., Ceoldo, S., Tarricone, E., Biral, D. and Salviati, G. (1999) Ecto-ATPase activity of α-sarcoglycan (adhalin). Biol. Chem., 274, 7907-7912.
61. Fougerousse, F., Durand, M., Suel, L., Pourquie, O., Delezoide, A., Romero, N.B., Abitbol, M. and Beckmann, J.S. (1998) Expression of genes (CAPN3, SGCA, SGCB and TTN) involved in progressive muscular dystrophies during early human development. Genomics, 48, 145-156.
62. Beckmann, J.S., Richard, I., Broux, O., Fougerousse, F., Allamand, V., Chiannilkulchai, N., Lim, L.E., Duclos, F., Bourg, N., Brenguier, L., Pasturaud, P., Quetier, F., Roudaut, C., Sunada, Y., Meyer, J., Dincer, P., Lefranc, G., Merlini, L., Topaloglu, H., Tome, F.M.S., Cohen, D., Jackson, C.E., Campbell, K.P. and Fardeau, M. (1996) Identification of muscle-specific calpain and β-sarcoglycan genes in progressive autosomal recessive muscular dystrophies. Neuromusc. Disord., 6, 455-462.
63. Richard, I., Roudaut, C., Saenz, A., Pogue, R., Grimbergen, J.E.M.A., Anderson, L.V.B., Beley, C., Cobo, A.-M., de Diego, C., Eymard, B., Galliano, P., Ginjaar, H.B., Lasa, A., Pollitt, C., Topaloglu, H., Urtizberea, J.A., de Visser, M., van der Kool, A., Bushby, K., Bakker, E., Lopez de Munain, A., Fardeau, M. and Beckmann, J.S. (1999) Calpainopathy - A survey of mutations and polymorphisms. Am. J. Hum. Genet., 64, 1524-1540.
64. Fardeau, M., Eymard, B., Mignard, C., Tome, F.M.S., Richard, I. and Beckmann, J.S. (1996) Chromosome 15-linked limb-girdle muscular dystrophy: clinical phenotypes in Reunion Island and French metropolitan communities. Neuromusc. Disord., 6, 447-453.
65. Ono, Y., Sorimachi, H. and Suzuki, K. (1998) Breakthroughs and views: structure and physiology of calpain, an enigmatic protease. Biochem. Biophys. Res. Commun., 245, 289-294.
66. Sorimachi, H., Kimura, S., Kinbara, K., Kazama, J., Takahashi, M., Yajima, H., Ishiura, S., Sasagawa, N., Nonaka, I., Sugita, H., Maruyama, K. and Suzuki, K. (1996) Structure and physiological functions of ubiquitous and tissue-specific calpain species. Adv. Biophys., 33, 101-122.
67. Sorimachiz, H., Toyama-Sorimachi, N., Saido, T.C., Kawasakai, H., Sugita, H., Miyasaka, M., Arahata, K., Ishiura, S. and Suzuki, K. (1993) Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J. Biol. Chem., 268, 10593-10605.
68. Spencer, M.J., Tidball, J.G., Anderson, L.V.B., Bushby, K.M.D., Harris, J.B., Passos-Bueno, M.R., Somer, H., Vainzof, K. and Zatz, M. (1997) Absence of calpain 3 in a form of limb-girdle muscular dystrophy (LGMD2A). J. Neurol. Sci., 146, 173-178.
69. Anderson, L.V.B., Davison, K., Moss, J.A., Richard, I., Fardeau, M., Tomé, F.M.S., Hubner, C., Lasa, A., Colomer, J. and Beckmann, J.S. (1998) Characterisation of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am. J. Pathol., 153, 1169-1179.
70. Kinbara, K., Sorimachi, H., Ishiura, S. and Suzuki, K. (1997) Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. Arch. Biochem. Biophys., 342, 99-107.
71. Sorimachi, H., Kinbara, K., Kimura, S., Takahashi, M., Ishiura, S., Sasagawa, N., Sorimachi, N., Shimada, H., Tagawa, K., Maruyama, K. and Suzuki, K. (1995) Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. Biol. Chem., 270, 31155-31162.
72. Baghdiguian, S., Martin, M., Richard, I., Pons, F., Astier, C., Bourg, N., Hay, R.T., Chemaly, R., Halaby, G., Loiselet, J., Anderson, L.V.B., de Munain, A.L., Fardeau, M., Mangeat, P., Beckmann, J.S. and Lefranc, G. (1999) Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IxBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A. Nature Med., 5, 503-511.
73. Ono, Y., Shimada, H., Sorimachi, H., Richard, I., Saido, T.C., Beckmann, J.S., Ishiura, S. and Suzuki, K. (1998) Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. Biol. Chem., 273, 17073-17078.
74. Achanzar, W.E. and Ward, S. (1997) A nematode gene required for sperm vesicle fusion. Cell Sci., 110, 1073-1081.
75. Yasunaga, S., Grati, M., Cohen-Salmon, M., El-Amraoui, A., Mustapha, M., Salem, N., El-Zir, E., Loiselet, J. and Petit, C. (1999) A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a non-syndromic form of deafness. Nature Genet., 21, 363-369.
76. 2+/phospholipid-binding fold. Cell, 80, 929-938.
77. Damer, C.K. and Creutz, C.E. (1994) Synergistic membrane interactions of the two C2 domains of synaptotagmin. Biol. Chem., 269, 41115-41123.
78. 2+-binding domain. J. Biol. Chem., 273, 15879-15882.
79. Anderson, L.V.B., Davison, K., Moss, J.A., Young, C., Cullen, M.J., Walsh, J., Johnson, M.A., Bashir, R., Britton, S., Keers, S., Argov, Z., Mahjneh, I., Fougerousse, F., Beckmann, J.S. and Bushby, K.M.D. (1999) Dysferlin is a plasma membrane protein and is expressed early in human development. Hum. Mol. Genet., 8, 855-861.
80. Illarioshkin, S.N., Ivanova-Smolenskaya, I.A., Tanaka, H., Poleshchuk, V.V., Markova, E.D. and Tsuji, S. (1997) Refined genetic location of the chromosome 2p-linked progressive muscular dystrophy gene. Genomics, 42, 345-348.
81. Illarioshkin, S.N., Ivanova-Smolenskaya, I.A., Tanaka, H., Vereshchagin, N.V., Markova, E.D., Poleshchuk, V.V., Lozhnikova, S.M., Sukhorukov, V.S., Limborska, S.A., Slominsky, P.A., Bulayeva, K.B. and Tsuji, S. (1996) Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy. Brain, 119, 1895-1909.
82. Weiler, T., Greenberg, C.R., Nylen, E., Halliday, W., Morgan, K., Eggertson, D. and Wrogemann, K. (1996) Limb-girdle muscular dystrophy and Miyoshi myopathy in an Aboriginal Canadian kindred map to LGMD2B and segregate with the same haplotype. Am. J. Hum. Genet., 59, 872-878.
83. Mahjneh, I., Passos-Bueno, M.R., Zatz, M., Vainzof, M., Marconi, G., Nashef, L., Bashir, R. and Bushby, K. (1996) The phenotype of chromosome 2p-linked limb-girdle muscular dystrophy. Neuromusc. Disord., 6, 483-490.
84. Speer, M.C., Gilchrist, J.M., Chutkow, J.G., McMichael, R., Westbrook, C.A., Stajich, J.M., Jorgenson, E.M., Gaskell, P.C., Rosi, B.L., Ramesar, R., Vance, J.M., Yamaoka, L.H., Roses, A.D. and Pericak-Vance, M.A. (1995) Evidence of locus heterogeneity in autosomal dominant limb-girdle muscular dystrophy. Am. J. Hum. Genet., 57, 1371-1376.
85. Speer, M.C., Gilchrist, J.M., Stajich, J.M., Yamaoka, L.H., Westbrook, C. and Pericak-Vance, M.A. (1994) Anticipation in autosomal dominant limb-girdle muscular dystrophy (LGMD1A). Am. J. Hum. Genet., 55, A7 (abstract).
86. van der Kooi, A.J., Ledderhof, T.M., de Voogt, W.G., Res, J.C.J., Bouwsma, G., Troost, D., Busch, H.F.M., Becker, A.E. and de Visser, M. (1996) A newly recognised autosomal dominant limb girdle muscular dystrophy with cardiac involvement. Ann. Neurol., 39, 636-642.